Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Transfection of embryo fibroblasts by a human ras oncogene does not convert them into tumour cells unless the fibroblasts are established and immortalized before transfection. The embryo fibroblasts become tumorigenic if a second oncogene such as a viral or cellular myc gene or the gene for the polyoma large-T antigen is introduced together with the ras gene.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, transformation of primary cells by ras requires either a cooperating oncogene or the inactivation of tumor suppressors such as p53 or p16.”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“ras cooperates, however, with certain other oncogenic alterations to transform primary rodent cells (Land et al. 1983; Ruley 1983), including overexpression of c-Myc, dominant negative p53, D-type cyclins, and Cdc25A and -B, and loss of p53, p16, or IRF-1”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“In that setting, dysfunctional telomeres induced a strong cellular senescence phenotype in the emerging lymphomas resulting in potent suppression of lymphomagenesis.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [93]
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,582
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., & Leder, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7837 · Cited by 1,422
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Self-citationRuley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Mulligan, R. C., & Berg, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2072 · Cited by 982
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Self-citationDer, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
Research works printed but not linked: 9
- Berenblum, I. & Shubik, P. Br. J. Cancer 1, 388 (1947).
- Emmelot, P. & Scherer, E. Cancer Res. 37, 1702–1708 (1977).
- Crawford, B. D., Barrett, J. C. & Ts'o, P. O. P. Molec. cell. Biol. 3, 931–945 (1983). · doi:10.1128/mcb.3.5.931
- Murray, M. J. et al. Cell (in the press).
- Aaronson, S. A. & Todaro, G. J. J. Cell Biol. 72, 141–148 (1968).
- Perucho, M., Hanahan, D. & Wigler, M. Cell 22, 309–317 (1980). · DOI · Paper page
- Beard, J. W. in Viral Oncology (ed. Klein, G.) 55–88 (Raven, New York, 1980).
- Adams, J. M., Gerondakis, S., Webb, E., Corcoran, L. & Cory, S. Proc. natn. Acad. Sci. U.S.A. (in the press).
- Gross, L. Oncogenic viruses, 931 (Pergamon, Oxford, 1970).
Cited by
Items 601–700 of 1,010
Simian virus 40 origin DNA-binding domain on large T antigen
Paucha, E., Kalderon, D., Harvey, R. W., & Smith, A. E. (1986) · Journal of Virology · doi:10.1128/jvi.57.1.50-64.1986 · Cited by 103
Transformation of human mammary epithelial cells by oncogenic retroviruses.
Clark, R., Stampfer, M. R., Milley, R., O’Rourke, E. C., Walen, K. H., Kriegler, M., Kopplin, J., & McCormick, F. P. (1988) · PubMed · Cited by 103
Kriegler, M. P., Perez, C. F., Hardy, C., & Botchan, M. R. (1984) · Cell · doi:10.1016/0092-8674(84)90503-8 · Cited by 103
Nonrandom loss of chromosome 15 in Syrian hamster tumours induced by v-Ha-ras plus v-myc oncogenes
Oshimura, M., Gilmer, T. M., & Barrett, J. C. (1985) · Nature · doi:10.1038/316636a0 · Cited by 103
Oncogenic Kras Initiates Leukemia in Hematopoietic Stem Cells
Sabnis, A. J., Cheung, L. S., Dail, M., Kang, H. C., Santaguida, M. A., Hermiston, M. L., Passegue, E. A., Shannon, K., & Braun, B. S. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000059 · Cited by 106
“Taken together, studies of myeloid oncogenes performed to date support the general idea that mutations that predominately alter cytoplasmic signaling networks and those that affect transcription factors controlling cell fate decisions comprise discrete complementation groups for the fully transformed phenotype [31,32].”
BackgroundCarlson, H., Ota, S., Song, Y., Chen, Y., & Hurlin, P. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205476 · Cited by 102
“…(C57Bl/6) embryos as previously described (Spector et al., 1998) and grown in DMEM supplemented with 10% FBS. Analogous to experiments pioneered by Land et al. (1983), focus formation (transformation) assays were performed by transfecting MEFs at passage 1 or 2 with combinations of pBabe ±Myc (a…”
MethodAberrant stabilization of c-Myc protein in some lymphoblastic leukemias
Malempati, S., Tibbitts, D., Cunningham, M., Akkari, Y. M. N., Olson, S. B., Fan, G., & Sears, R. C. (2006) · Leukemia · doi:10.1038/sj.leu.2404317 · Cited by 102
Hirning-Folz, U., Schmid, P., Schulz, W. A., Rettenberger, G., & Hameister, H. (1991) · Mechanisms of Development · doi:10.1016/0925-4773(91)90078-k · Cited by 102
Definition of the activities and properties of c-myc required to inhibit cell differentiation.
Freytag, S. O., Dang, C. V., & Lee, W. M. (1990) · PubMed · Cited by 105
Anzano, M. A., Roberts, A. B., & Sporn, M. B. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041260223 · Cited by 104
Radioresistance Induced by Oncogenic Transformation
Ling, C. C., & Endlich, B. (1989) · Radiation Research · doi:10.2307/3577713 · Cited by 102
Role of Cyclin B1 Levels in DNA Damage and DNA Damage-Induced Senescence
Nakayama, Y., & Yamaguchi, N. (2013) · International review of cytology · doi:10.1016/b978-0-12-407695-2.00007-x · Cited by 112
Radna, R. L., Caton, Y., Jha, K. K., Kaplan, P., Li, G., Traganos, F., & Ozer, H. L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.7.3093-3096.1989 · Cited by 26
Myelodysplastic syndromes: pathogenesis, functional abnormalities, and clinical implications.
Jacobs, A. J. (1985) · Journal of Clinical Pathology · doi:10.1136/jcp.38.11.1201 · Cited by 104
Sklar, M. D., Tereba, A., Chen, B. D. ‐., & Walker, W. S. (1985) · Journal of Cellular Physiology · doi:10.1002/jcp.1041250307 · Cited by 98
Cowling, V. H., Chandriani, S., Whitfield, M. L., & Cole, M. D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01959-05 · Cited by 92
“Cooperation between these oncogenes results in foci on the cell monolayer (31).”
BackgroundDrosophila Myc is oncogenic in mammalian cells and plays a role in the diminutive phenotype
Schreiber-Agus, N., Stein, D., Chen, K., Goltz, J. S., Stevens, L., & DePinho, R. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1235 · Cited by 99
Pattengale, P. K., Stewart, T. A., Leder, A., Sinn, E., Muller, W. J., Tepler, I., Schmidt, E. V., & Leder, P. (1989) · PubMed Central · Cited by 122
ONCOGENES IN RHEUMATOID ARTHRITIS
Müller‐Ladner, U., Kriegsmann, J., Gay, R. E., & Gay, S. (1995) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(21)00462-2 · Cited by 105
Kaye, F. J., Battey, J. F., Nau, M. M., Brooks, B., SEIFTER, E. J., Grève, J. D., Birrer, M. J., Sausville, E. A., & Minna, J. D. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.186 · Cited by 100
Faletto, D. L., Arrow, A. S., & Macara, I. G. (1985) · Cell · doi:10.1016/0092-8674(85)90037-6 · Cited by 100
Mutant N-ras Induces Myeloproliferative Disorders and Apoptosis in Bone Marrow Repopulated Mice
MacKenzie, K. L., Dolnikov, A., Millington, M., Shounan, Y., & Symonds, G. P. (1999) · Blood · doi:10.1182/blood.v93.6.2043.406k17_2043_2056 · Cited by 99
Lu, Z., Hornia, A., Joseph, T., Sukezane, T., Frankel, P., Zhong, M., Bychenok, S., Xu, L., Feig, L. A., & Foster, D. A. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.2.462-467.2000 · Cited by 98
“Weinberg and colleagues characterized complementation groups of oncogenes that transform primary cells (10, 15, 26).”
BackgroundTransformation by human adenoviruses
Branton, P. E., Bayley, S. T., & Graham, F. L. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(84)90007-6 · Cited by 99
Loss of the normal N-ras allele in a mouse thymic lymphoma induced by a chemical carcinogen.
Guerrero, I., Villasante, A., Corces, V, & Pellicer, A. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.23.7810 · Cited by 102
Activation of c-myc and c-K-ras Oncogenes in Primary Rat Tumors induced by Ionizing Radiation
Sawey, M. J., Hood, A. T., Burns, F. J., & GARTE, S. J. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.2.932 · Cited by 99
Ohno, S., Migita, S., Wiener, F., Babonits, M., Klein, G., Mushinski, J. F., & Potter, M. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.159.6.1762 · Cited by 99
“Further, in transforming experiments involving transfection with myc gene sequences, the myc gene alone is not able to transform cells to full neoplasia by itself (45), whereas it, as well as E1A, can cooperate with ras in inducing transformation.”
BackgroundMethodZhu, Z., Veldman, G. M., Cowie, A., Carr, A. M., Schaffhausen, B. S., & Kamen, R. (1984) · Journal of Virology · doi:10.1128/jvi.51.1.170-180.1984 · Cited by 99
“The modified polyomavirus genomes whose construction and characterization are described have already been instrumental in the elucidation of oncogenic transformation induced by both viral and cellular oncogenes (23, 30-32, 35, 46).”
BackgroundMethodRegulation of actin organisation by TGF-β in H-ras-transformed fibroblasts
Moustakas, A., & Stournaras, C. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.8.1169 · Cited by 98
Drayton, S., Rowe, J., Jones, R., Vatcheva, R., Heavens, D., Marshall, J. F., Fried, M., & Peters, G. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00242-3 · Cited by 98
Oláh, E., Natsumeda, Y., Ikegami, T., Kote, Z., Horányi, M., Szelényi, J., Paulik, E., Kremmer, T., Hollan, S. R., & SUGÁR, J. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6533 · Cited by 98
Twisted epithelial–mesenchymal transition blocks senescence
Weinberg, R. A. (2008) · Nature Cell Biology · doi:10.1038/ncb0908-1021 · Cited by 97
Self-citationRibosomal Protein S14 Negatively Regulates c-Myc Activity
Zhou, X., Hao, Q., Liao, J.-M., Liao, P., & Lu, H. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.445122 · Cited by 92
“The Myc overexpression was shown to boost oncogenesis in cells (4) and in transgenic mouse models (5–7).”
BackgroundConstitutional aneuploidy and cancer predisposition
Ganmore, I., Smooha, G., & Izraeli, S. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp084 · Cited by 109
“This phenomenon is similar to classical requirement for cooperative oncogenic activity to overcome the senescence or cell death induced by single oncogenes (131).”
BackgroundNAD-dependent methylenetetrahydrofolate dehydrogenase is expressed by immortal cells.
Mejia, N. R., & MacKenzie, R. E. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38612-x · Cited by 96
Chapter 16 Regulation of Protein Activities by Fusion to Steroid Binding Domains
Mattioni, T., Louvion, J.-F., & Picard, D. (1994) · Methods in cell biology · doi:10.1016/s0091-679x(08)60611-1 · Cited by 97
Genetic and cellular basis of multistep carcinogenesis
Boyd, J. A., & Barrett, J. C. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90028-z · Cited by 107
Facilitating replication under stress: an oncogenic function of MYC?
Herold, S., Herkert, B., & Eilers, M. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2640 · Cited by 104
“These findings may also be relevant for our understanding of the cooperation of oncogenes during transformation of primary cells: in primary cells, activated cytosolic oncogenes, such as oncogenic Ras proteins or BRAF , require MYC for transformatio”
Kottakis, F., Foltopoulou, P. F., Sanidas, I., Keller, P. J., Wronski, A., Dake, B. T., Ezell, S. A., Shen, Z., Naber, S. P., Hinds, P. W., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2733 · Cited by 96
“S1A–S1C), suggesting that NDY1/KDM2B is protumorigenic (19).”
Family matters: How MYC family oncogenes impact small cell lung cancer
Brägelmann, J., Böhm, S., Guthrie, M. R., Mollaoglu, G., Oliver, T. G., & Sos, M. L. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1339849 · Cited by 99
Eddy, J. A., Hood, L., Price, N. D., & Geman, D. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000792 · Cited by 96
“For example, cooperating oncogenes interact synergistically to evade tumor suppression mechanisms such as cell-cycle arrest and apoptosis [3,4].”
BackgroundHass, B. S., Hart, R. W., Lu, M. H., & Lyn‐Cook, B. D. (1993) · Mutation Research/DNAging · doi:10.1016/0921-8734(93)90026-y · Cited by 103
Corominas, M., Kamino, H., León, J., & Pellicer, À. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.16.6372 · Cited by 106
A hemodynamic load in vivo induces cardiac expression of the cellular oncogene, c-myc
Mulvagh, S. L., Michael, L. H., Perryman, M. B., Roberts, R., & Schneider, M. D. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90977-6 · Cited by 95
Kingston, R. E., Kaufman, R. J., & Sharp, P. A. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.10.1970 · Cited by 95
The significance of telomerase activation and cellular immortalization in human cancer
Newbold, R. F. (2002) · Mutagenesis · doi:10.1093/mutage/17.6.539 · Cited by 101
“Independent and simultaneous studies showed that rat fibroblasts could be fully transformed by co-transfection of ras with either a myc oncogene (Land et al., 1983) or the gene encoding the largeT antigen of simian virus (SV) 40 (Ruley, 1983) suggesting that combinations of oncogenes may be needed for malignant transf…”
BackgroundWillems, L., Heremans, H., Chen, G., Portetelle, D., Billiau, A., Burny, A., & Kettmann, R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08277.x · Cited by 105
Park, J., Yang, J. M., & Min, M.-K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1999 · Cited by 94
Stepanova, L., Finegold, M. J., DeMayo, F. J., Schmidt, E. V., & Harper, J. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4462-4473.2000 · Cited by 102
“c-myc can collaborate with ras to transform a variety of cell types both in vitro and in vivo (26, 56).”
BackgroundLin, H.-J. L., Eviner, V., Prendergast, G. C., & White, E. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4536 · Cited by 93
“In vitro studies have shown that H-ras cooperates with E1A or with c-myc to transform cells (22, 33), leading to the possibility that H-ras is an apoptosis inhibitor.”
BackgroundAbrogation by c-myc of Gl phase arrest induced by RB protein but not by p53
Goodrich, D. W., & Lee, W. (1992) · Nature · doi:10.1038/360177a0 · Cited by 105
Transformation-sensitive and Growth-related Changes of Protein Synthesis in REF52 Cells
Garrels, J. I., & Franza, B. R. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83730-9 · Cited by 94
The karyotype of blastic crisis
Alimena, G., Cuia, M. R. D., Diverio, D., Gastaldi, R., & Nanni, M. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90131-2 · Cited by 93
Regulation of transcription factors by nitric oxide in neurons and in neural-derived tumor cells
Contestabile, A. (2008) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.01.002 · Cited by 104
Kirsten Ras* oncogene: Significance of its discovery in human cancer research
Tsuchida, N., Murugan, A. K., & Grieco, M. (2016) · Oncotarget · doi:10.18632/oncotarget.8773 · Cited by 102
“” The discovery of (i) the enhanced expression of the human cellular MYC gene (c-MYC) following its translocation to the immunoglobulin heavy chain enhancer locus in Burkitt’s lymphoma [39], and (ii) the immortalization of primary rat embryo cells by promoter-linked human c-MYC [40] also contributed to this rise in “o…”
BackgroundGeorgescu, H. I., Mendelow, D., & Evans, C. H. (1988) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02620875 · Cited by 93
“Depending on the species and type of cell, immortalization may be induced chemically (31), virally (32), or by transfection with certain oncogenes (26,30).”
BackgroundTargeting HER2: Recent developments and future directions for breast cancer patients
Wang, S.-C., Zhang, L., Hortobágyi, G. N., & Hung, M. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90105-8 · Cited by 104
Progression: The Terminal Stage in Carcinogenesis
Pitot, H. C. (1989) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1989.tb01683.x · Cited by 93
Boerner, P., Resnick, R. J., & Racker, E. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.5.1350 · Cited by 93
Parkinson, E. K. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.219 · Cited by 93
“The role of selection in tumour promotion It was recently shown that more than one oncogene must be activated in concert to malignantly transform fibroblasts (Ruley, 1983, Land et al., 1983, Newbold & Overell, 1983).”
BackgroundL-myc Cooperates with ras to Transform Primary Rat Embryo Fibroblasts
Birrer, M. J., Segal, S., DeGreve, J. S., Kaye, F. J., Sausville, E. A., & Minna, J. D. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.6.2668 · Cited by 93
Contrasting roles for Myc and Mad proteins in cellular growth and differentiation.
Chin, L., Schreiber-Agus, N., Pellicer, I., Chen, K., Lee, H. W., Dudast, M., Cordon-Cardo, C., & DePinho, R. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8488 · Cited by 93
Zhu, J., Rice, P. W., Gorsch, L. C., Abate, M., & Cole, C. N. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2780-2791.1992 · Cited by 101
Slack, A., Cervoni, N., Pinard, M., & Szyf, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10105 · Cited by 93
Smith, E., Coetzee, G. A., & Frenkel, B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109708200 · Cited by 92
Groth, A., Weber, J. D., Willumsen, B. M., Sherr, C. J., & Roussel, M. F. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61532-2 · Cited by 92
Amplification and expression of protooncogenes in human small cell lung cancer cell lines
Kiefer, P. (1989) · Lung Cancer · doi:10.1016/0169-5002(89)90368-1 · Cited by 92
“gene in SCLC suggest that these genes may play an important role in tumor establishment (35, 37).”
BackgroundYamamura, S., Saini, S., Majid, S., Hirata, H., Ueno, K., Chang, I., Tanaka, Y., Gupta, A., & Dahiya, R. (2012) · Carcinogenesis · doi:10.1093/carcin/bgr286 · Cited by 90
“co-operating oncogene such as ras oncogene [35], c-Myc is one of the major factors in”
BackgroundThe role of Raf kinases in malignant transformation
Kölch, W., Kotwaliwale, A., Vass, K., & Janosch, P. (2002) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399402004386 · Cited by 91
Mnt Loss Triggers Myc Transcription Targets, Proliferation, Apoptosis, and Transformation
Nilsson, J. A., Maclean, K. H., Keller, U. B., Pendeville, H., Baudino, T. A., & Cleveland, J. L. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.4.1560-1569.2004 · Cited by 93
“Interestingly, the notion that relieving Mnt-mediated transrepression is sufficient to activate genes involved in transformation is supported by experiments demonstrating that a deletion mutant of Mnt lacking the Sin3 interaction domain is capable of transforming primary rat embryo fibroblasts in conjunction with Ha-R…”
InfluentialRequirement for the Simian Virus 40 Small Tumor Antigen in Tumorigenesis in Transgenic Mice
Choi, Y., Lee, I. C., & Ross, S. R. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3382 · Cited by 91
Identification of a region of simian virus 40 large T antigen required for cell transformation
Chen, S., & Paucha, E. (1990) · Journal of Virology · doi:10.1128/jvi.64.7.3350-3357.1990 · Cited by 91
“It has been reported that in some cases, transformation of primary cells in culture is a multistep process in which immortalization or establishment can be separated genetically from expression of the phenotypic properties of transformation (17, 35).”
BackgroundWoodworth, C. D., Secott, T. E., & Isom, H. C. (1986) · PubMed · Cited by 91
Vousden, K. H., & Marshall, C. J. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb01905.x · Cited by 91
Activated Ras induces a proangiogenic phenotype in primary endothelial cells
Meadows, K. N., Bryant, P. W., Vincent, P. A., & Pumiglia, K. M. (2004) · Oncogene · doi:10.1038/sj.onc.1206921 · Cited by 90
“Active Ras induces proliferation and cellular transformation in immortalized cells (Land et al., 1983; Newbold and Overell, 1983; Yoakum et al., 1985) and some primary cell types (Gire et al., 1999).”
BackgroundSystems pharmacology and genome medicine: a future perspective
Wist, A. D., Berger, S., & Iyengar, R. (2009) · Genome Medicine · doi:10.1186/gm11 · Cited by 97
“The two-hit model for cancer [11] was an early example of this recognition.”
BackgroundBarré, B., Vigneron, A., & Coqueret, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413203200 · Cited by 86
Oncogene-dependent Regulation of Caspase Activation by p53 Protein in a Cell-free System
Ding, H.-F., McGill, G., Rowan, S., Schmaltz, C., Shimamura, A., & Fisher, D. E. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.43.28378 · Cited by 91
Gandrillon, O., Jurdic, P., Benchaibi, M., Xiao, J. H., Ghysdael, J., & Samarut, J. (1987) · Cell · doi:10.1016/0092-8674(87)90545-9 · Cited by 96
Oncogenes and Cancer: The p21rasGenes
Shih, T. Y., & Weeks, M. O. (1984) · Cancer Investigation · doi:10.3109/07357908409020294 · Cited by 90
Mccarthy, D., Goldman, J. M., Rassool, F., Graham, S. V., & Birnie, G. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92058-0 · Cited by 90
Macieira‐Coelho, A. (1986) · Experimental Gerontology · doi:10.1016/0531-5565(86)90001-x · Cited by 89
N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis
Lübbert, M., Mirro, J., Cw, M., Kahan, J., Isaac, G., Kitchingman, G. R., Mertelsmann, R., Herrmann, F., McCormick, F. P., & Koeffler, H. (1990) · Blood · doi:10.1182/blood.v75.5.1163.1163 · Cited by 89
Post-transcriptional Regulation of the Arginine Transporter Cat-1 by Amino Acid Availability
Aulak, K. S., Mishra, R., Zhou, L., Hyatt, S. L., de Jonge, W., Lamers, W., Snider, M., & Hatzoglou, M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.43.30424 · Cited by 86
Myc represses transcription of the growth arrest gene gas1
Lee, T. C., Li, L., Philipson, L., & Ziff, E. B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.12886 · Cited by 89
Transformation by and Oncogenicity of Human Adenoviruses
Graham, F. L. (1984) · Springer eBooks · doi:10.1007/978-1-4684-7935-5_9 · Cited by 105
LaFemina, R. L., & Hayward, G. S. (1986) · Journal of Virology · doi:10.1128/jvi.58.2.434-440.1986 · Cited by 96
“In addition, c-myc and Ela display homologous protein domains (24) and have been placed in the same transformation complementation group (22).”
BackgroundNo Effect of 60 Hz Electromagnetic Fields on MYC or β-Actin Expression in Human Leukemic Cells
Lacy‐Hulbert, A., Wilkins, R. C., Hesketh, T. R., & Metcalfe, J. C. (1995) · Radiation Research · doi:10.2307/3579230 · Cited by 95
Expressions of the c-Ha-rasand c-mycgenes in rat liver tumors
Makino, R., Hayashi, K., Sato, S., & Sügimura, T. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)90887-8 · Cited by 89
Molecular damage in cancer: an argument for mTOR-driven aging
Blagosklonny, M. V. (2011) · Aging · doi:10.18632/aging.100422 · Cited by 90
“There are non-mutually exclusive ways to depict oncogenic transformation, as complementary activation/ disabling of signaling pathways [88, 217-225].”
BackgroundTrosko, J. E. (2009) · Veterinary Pathology · doi:10.1354/vp.46-2-176 · Cited by 88
Redox Regulation of Precursor Cell Function: Insights and Paradoxes
Noble, M., Mayer‐Pröschel, M., & Pröschel, C. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1456 · Cited by 99
“…active mutant ras allele is introduced into a cell that has been immortalized (for example, by expression of v-myc or SV40 large T antigen), the cell becomes fully transformed, able to grow in an anchorage-independent anchorage-independent manner and without exogenously supplied mito-gens (42).”
Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras
Sommer, K. W., Schamberger, C. J., Schmidt, G., Sasgary, S., & Cerni, C. (2003) · Oncogene · doi:10.1038/sj.onc.1206509 · Cited by 88
“Thus, the proven cooperation of cmyc with c-H-ras in primary REC (Land et al., 1983; Cerni et al., 1995, 2002; Simonitsch et al., 2001) was hampered by reduced amounts of endogenous survivin.”
BackgroundOncogenes in Retroviruses and Cells: Biochemistry and Molecular Genetics
Bister, K., & Jansen, H. W. (1986) · Advances in cancer research · doi:10.1016/s0065-230x(08)60199-2 · Cited by 95
Corcoran, L. M., Cory, S., & Adams, J. M. (1985) · Cell · doi:10.1016/0092-8674(85)90310-1 · Cited by 88
Potentiation of growth factor activity by exogenous c-myc expression.
Sorrentino, V., DROZDOFF, V., McKinney, M. D., Zeitz, L., & Fleissner, E. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8167 · Cited by 95
Bedford, J. S., & Dewey, W. C. (2002) · Radiation Research · doi:10.1667/0033-7587(2002)158[0251:hachir]2.0.co;2 · Cited by 104
“Weinberg and his colleagues showed this to be the case in a striking result where RAS and MYC oncogenes transfected together did produce full transformation where neither alone did (237).”
BackgroundLi, H., Velasco-Miguel, S., Vass, W. C., Parada, L. F., & DeClue, J. E. (2002) · PubMed · Cited by 98
Self-citationCell-cycle-specific genes differentially expressed in human leukemias.
Calabretta, B., Kaczmarek, L., Mars, W., Ochoa, D., Gibson, C. W., Hirschhorn, R. R., & Baserga, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.13.4463 · Cited by 97
The c-myc gene encodes superimposed RNA polymerase II and III promoters
Chung, J. H., Sussman, D. J., Zeller, R., & Leder, P. (1987) · Cell · doi:10.1016/0092-8674(87)90586-1 · Cited by 87
Metadata
- Authors
- Land, H., Parada, L. F., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Venue
- Nature
- Published
- 1983-08
- Volume
- 304
- Issue
- 5927
- Pages
- 596-602
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989009382
- Cited by
- 2,804
- References
- 56
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 22 · 2023: 15 · 2022: 17 · 2021: 24 · 2020: 22 · 2019: 36 · 2018: 17 · 2017: 23 · 2016: 24 · 2015: 39 · 2014: 27 · 2013: 30 · 2012: 37
- FWCI
- 96.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- embryonic fibroblasts, oncogene cooperation, oncogenic Ras, MYC gene, polyomavirus large T antigen, cell immortalization, transfection
- MeSH terms
- Animals, Antigens, Viral, Antigens, Viral, Tumor, Cell Line, Cell Transformation, Viral, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Genes, Viral, Genetic Complementation Test, Oncogenes, Phenotype, Polyomavirus, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.